Note: This document contains side effect information about haemophilus b conjugate (prp-omp) vaccine. Some dosage forms listed on this page may not apply to the brand name Liquid PedvaxHIB.
Applies to haemophilus b conjugate (prp-omp) vaccine: intramuscular suspension.
Warning
Tell your doctor if your child uses other medicines or have other medical conditions or allergies.
Get emergency medical help if your child has signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Keep track of any and all side effects your child has after receiving this vaccine. When the child receives a booster dose, you will need to tell the doctor if the previous shot caused any side effects.
Call your doctor at once if your child has:
-
high fever (within a few hours or a few days after the vaccine);
-
a seizure; or
-
fussiness, irritability, crying for an hour or longer.
Common side effects may include:
-
irritability, crying;
-
drowsiness;
-
diarrhea, vomiting;
-
rash;
-
pain, swelling, or redness where the shot was given;
-
cold symptoms such as stuffy nose, sneezing, sore throat; or
-
ear infection--fever, ear pain or full feeling, trouble hearing, drainage from the ear, fussiness in a child.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects.
For Healthcare Professionals
Applies to haemophilus b conjugate (prp-omp) vaccine: intramuscular suspension.
General
The most common adverse events were irritability, sleepiness, injections site pain/soreness, injection site swelling, unusual high-pitched crying, prolonged crying (over 4 hours), diarrhea, vomiting, crying, pain, otitis media, rash, and upper respiratory infection.[Ref]
Other
Very common (10% or more): Fever over 38.3C (rectal) (18.1%)
Common (1% to 10%): Unusual high-pitched crying, prolonged crying (over 4 hours), crying, pain[Ref]
Gastrointestinal
Common (1% to 10%): Diarrhea, vomiting
Frequency not reported: Urticaria[Ref]
Local
Common (1% to 10%): Erythema over 2.5 cm diameter, swelling over 2.5 cm diameter, injection site pain/soreness
Postmarketing reports: Sterile injection site abscess[Ref]
Psychiatric
Common (1% to 10%): Irritability, sleepiness[Ref]
Immunologic
Common (1% to 10%): Otitis media, upper respiratory infection[Ref]
Dermatologic
Common (1% to 10%): Rash
Postmarketing reports: Angioedema[Ref]
Nervous system
Postmarketing reports: Febrile seizures[Ref]
Hematologic
Frequency not reported: Thrombocytopenia[Ref]
Respiratory
Frequency not reported: Tracheitis[Ref]
